Five Prime Therapeutics, Inc. Diluted Shares Outstanding (Weighted Average)
Five Prime Therapeutics, Inc. reported Diluted Shares Outstanding (Weighted Average) of 34.97 million shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2020-02-27
- Five Prime Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2019 was 34.97M shares, a 2.93% increase from fiscal 2018.
- Five Prime Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2018 was 33.98M shares, a 21.58% increase from fiscal 2017.
- Five Prime Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2017 was 27.95M shares, a 3.67% increase from fiscal 2016.
- Five Prime Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2016 was 26.95M shares, a 0.30% decline from fiscal 2015.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|
| 2019-12-31 | 34.97M shares 10-K · filed 2020-02-27 |
| 2018-12-31 | 33.98M shares 10-K · filed 2020-02-27 |
| 2017-12-31 | 27.95M shares 10-K · filed 2020-02-27 |
| 2016-12-31 | 26.95M shares 10-K · filed 2019-02-26 |
| 2015-12-31 | 27.04M shares 10-K · filed 2018-02-27 |
| 2014-12-31 | 20.86M shares 10-K · filed 2017-02-24 |
| 2013-12-31 | 5.52M shares 10-K · filed 2016-03-11 |
| 2012-12-31 | 1.20M shares 10-K · filed 2015-03-18 |
| 2011-12-31 | 1.90M shares 10-K · filed 2014-03-26 |